Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by canadafanon Dec 20, 2022 11:07am
151 Views
Post# 35182144

RE:Newbies beware ---this stock is pure garbage

RE:Newbies beware ---this stock is pure garbageFunny Davepark5 talks about 5 years ago, yet he has only been on Stockhouse for 2 years.
have to wonder who is making things up,
BTW.
five years ago, they did not have fast track with both  Roche ( pancreatic cancer) & Pfizer ( MBc cancer).
The most recent panc cancer results lead to a quick FDA fast track approval.
watching the SP lately is like watching an elevator.
Only difference, the lower floors have been less frequent & the upper floors ...well higher.
have to ask, why would anyone holding Onc or any company shares bash his/ her investment?
The logical thing to do? If you feel that bad about the company prospects, sell & move on.
reslity, I agree it has been a rough ride ( for the share price).
however, operationally they have made not good, but great strides in the past 6 months.
The recent presentation by Adlai Nortye & the Roche panc cancer results are both in a very positive direction.
Quite frankly ALL of the news over last year has been positive.
So we have a very obvious mismatch between the operating results & share price.
One of a few options need to fix that imbalance.
1. A buyout
2. partnership with one of Roche, Pfizer, Incyte or Merck
3. bad news to validate the silly low price.
saying that anyone paying attention is well aware, there is an intentional group trying to bash the price down.
Why? Shorting? Wanting to buy lower & ride the elevator.
regardlass. Please visit the oncolytics biotch investor presentation.
dont take my word.

<< Previous
Bullboard Posts
Next >>